Now I know how Galileo felt

An astonishing article appeared in “The Guardian” on 30th October.  You can find it at https://www.theguardian.com/lifeandstyle/2018/oct/30/butter-nonsense-the-rise-of-the-cholesterol-deniers.  Basically it states that accepted wisdom over the dangers of cholesterol is correct, and those that seek to deny this are dangerous lunatics.  The article is shot through with snide digs at the deniers, implying they are not proper researchers because they don’t hold tenured posts, that their opinions are published in obscure or second-rate journals and that their views are as damaging as Andrew Wakefield’s views on MMR vaccine causing autism.

When Galileo (and Copernicus for that matter) first suggested, with good scientific evidence, that the earth went round the sun he was subjected to abuse, vilification and was ostracised.  Every attempt was made by the scientists of the day to rubbish his theory. Oh well, it was suggested, he isn’t a proper astronomer, so what does he know to produce a theory that all we experts refute categorically?

Sounds familiar, perhaps.

Let’s get a few things straight. I was a rheumatologist in my working life, so deferred to my cardiology colleagues on matters cardiac.  When I found my serum cholesterol was very high I consulted my GP and readily accepted the prescription of a statin.  I developed an odd inflammation in my shin shortly after the first statin.  The technical term was tenosynovitis of the tibialis anterior muscle; in lay terms this was pain on walking, with a peculiar grating feeling if I put my hand over my shin and worked the muscle.  I had never encountered this among the myriad soft tissue lesions I saw in my clinics so consulted the Internet, where I found a case report of the condition related to statin intake.  So I stopped my statin .  The problem went away.  I sought further advice.  My GP gave me another one.  This time within 24 hours I had developed severe shoulder and hip girdle muscle pains, so bad during the night that I was unable to sleep.  I attributed this to the new statin, and stopped that.  After an interval I was prescribed yet another.  I had no adverse effects for a couple of months, and then found I was struggling to climb hills and could not lift heavy garden items.  On a long slope I simply ran out of steam, and had to stop and wait a few minutes.  Normally I could lift two 50 litre bags of compost together; now i could not lift even one.

By this time I had discovered the existence of statin myalgia, so took myself to the hospital lab to get my blood checked.  My creatine kinase level (that’s an enzyme which goes up with muscle damage, or rhabdomyolysis) was significantly elevated.  I consulted a lipid specialist and we agreed I should not take them any more.  My cholesterol remains high.

I write this preamble because the anti-Galileans of the cholesterol world talk blithely of a nocebo effect – one where you get a side-effect because you are expecting to get one. – which explains, in their eyes, the reports of side-effects that they claim are grossly exaggerated in numbers.  But you can’t suffer from a nocebo effect if you don’t expect it.  Neither can such an effect cause significant enzyme changes on blood tests.  Never mind; whatever the real incidence that’s not entirely relevant to this piece, but my experience led me to a new world of the cholesterol-heart hypothesis, and to the statin skeptic network called THINCS.  And we are, I believe, modern Galileos, whose questioning of received wisdom (if you can call it that) is beginning to lead to denigration and persecution.  Will we be proved right?  Let’s look at some facts.

It is undeniable that statins do reduce the risk of a major cardiac event.  But the first question is – by how much?  If you read the statin-favourable reports and research studies you will think that the risk reduction is around 50%, which is pretty impressive.  However you must ask first what the risk was in the first place.  If the risk is 4%, then a reduction of 50% means it becomes 2%.  So it’s not really very impressive at all.  Statistics are not easy; I have seen many examples of trials conducted by perfectly respectable researchers who have used the wrong statistical analysis method by accident (or ignorance) and not-so-respectable ones who find a method, or select data, so they produce an apparently significant result.  But quoting a risk reduction of 50% – the relative reduction – is deception when the absolute reduction is only 2%.  Why do people do this?  It makes the results look better, but in the end they start believing their own myths.  And if you look at the prolongation of life it amounts to a few days, let alone years.  Not a lot, as Paul Daniels would have said.

So the effects of statins are overstated and misrepresented.

The next question is why do statins reduce risk (although perhaps, as the reduction is so piddling, we shouldn’t bother).  But I did bother, because I found something that blew the whole cholesterol thing out of the water.

There is unimpeachable evidence that if you suffer from severe rheumatoid arthritis (RA) then your risk a a major cardiovascular event is very high – possibly even higher than if you are diabetic.  If you successfully treat the arthritis with so-called disease-modifying drugs, this risk reduces substantially.  But the cholesterol level in the blood goes up.

Here we have an oxymoron. Give statins, cholesterol falls and cardiac risk falls (a bit).  Give drugs that make RA patients better, cholesterol rises, but cardiac risk falls (quite a lot).  Explain.

For about seven years I put this paradox to rheumatologists, physicians and others. No-one could explain it.  They huffed and puffed and mumbled and came up with all manner of crazy theories.  So we have a Black Swan.  Received wisdom in the eighteenth century was that all swans were white. Then Australia was discovered and lo! there were black ones. So the received wisdom was wrong. It only takes a single contrary observation to destroy a theory.  In medicine one tests a theory exactly thus; you make a hypothesis, and set out to disprove it (it’s called a null hypothesis).  The null hypothesis is that statins  reduce cardiac risk because they reduce cholesterol.  Yet if we reduce cardiac risk by treating a disease characterised by inflammation, cholesterol goes up.  So the null hypothesis is by definition proved to be false.  You can have any number of things supporting a null hypothesis, but it takes just one that doesn’t to turn things over.

Enter Malcolm Kendrick, another cholesterol skeptic, a deep thinker, careful research analyst, and GP without some giant research department (therefore suspect in the eyes of the anti-Galileans). What if the mechanism of action of statins has nothing to do with cholesterol?  Suppose that cardiovascular risk is increased because of blood vessel inflammation and that statins reduce this?  Well.  It all fits, doesn’t it? And by golly there’s plenty of evidence for coronary artery inflammation.  You get it in RA and other connective tissue diseases.  You find it on pathological examination under a microscope.  And it explains otherwise inexplicable things.  Like – how does a large cholesterol molecule get through the blood vessel wall?  It can’t, if the wall is intact, because it’s too big.  But suppose the wall is damaged, and tries to repair itself, but the process doesn’t quite work.  Why, then you can find cholesterol the wrong side of the wall lining.  It’s there as part of an incomplete healing process.  It has nothing whatever to do with its concentration in the blood but will happen more often where there is blood vessel damage.  Oh, and by the way, that occurs in diabetics and smokers too.  There are an awful lot of scientists and cardiologists who find this hypothesis attractive, and despite asking the anti-Galileans to pick it to pieces for some reason they haven’t.  Perhaps they can’t but I would like to see them try.

I would prefer to explain this as follows: Statin use (A) causes a small reduction in cardiac risk (B).  A also causes a fall in cholesterol (C).  A leads to B, and A leads to C.  But that does not mean that C leads to B.  A fall in cholesterol is more likely to be a side-effect, or epiphenomenon – something clearly observable but irrelevant.

Another question of mine has been why you find cholesterol deposits in arteries, but not in veins, where the pressure is less and the flow can be sluggish.  If cholesterol was to be deposited anywhere it ought to be here, like silt in a river. Explain. (Actually don’t bother, because there’s more coming that makes that unnecessary).

So statins work by reducing inflammation; that they reduce cholesterol is by the by.  Now I don’t really care whether severe statin side-effects occur in 20 % or 2% but others do, on the basis that if patients cannot take a statin they MUST HAVE SOMETHING!!!  You would be amazed at the number of people I saw with clear-cut statin side-effects (effect occurs, stop, effect disappears, restart, effect reappears – that’s called re-challenge, and QED for cause and effect) who were otld, 0redered even, to carry on because otherwise they would DIE!

So a new injectable drug was produced called evolucumab.  Its cholesterol-lowering effects are remarkable.  It’s far, far better than a statin.  It’s also very, very expensive.  Does it reduce cardiac events far, far better than a statin?  No!  Why not? Perhaps it doesn’t have any anti-inflammatory properties, but we won’t know in all probability as the major trial looking at outcomes was terminated early.  The death rate in those on the active drug was higher.  There is a suspicion that it would have been higher still if the trial had continued.  Even Sir Richard Thompson, past president of the Royal College of Physicians, said any benefit was “amazingly small”.  So here is another oxymoron.  Statins reduce cholesterol a bit and reduce cardiac events a bit.  Evolucumab reduces cholesterol a lot but doesn’t reduce cardiac events.  Explain.

Well, the obvious explanation is that any cardiac benefits of statins have nothing to do with cholesterol.

Next question.  Where does cholesterol come from?

You thought you ate it, didn’t you?  It’s in all that butter and other saturated fat that forms such a large part of your diet.  Actually it’s not that large a part, but anyway most of the cholesterol you find in the bloodstream (80% or so) is made in the liver.  From what, you ask? How about carbohydrate?  Whatever, an increase in dietary cholesterol slows the liver’s own production (this is called homeostasis).  So fiddling with your cholesterol intake is not much use, as your liver will defy your good intentions and simply make more.  If your level is high, probably your genes made you that way.

I wonder whether you are beginning to doubt received wisdom.  It is interesting, if sad, that the whole concept of cholesterol irrelevance was effectively proposed several decades ago by Dr John Yudkin, who saw sugar as the villain, but who was himself vilified and ostracised.  And the work of Ancel Keys who was key (sorry) to the adoption of the cholesterol-heart hypothesis, was fatally flawed.  Out of the countries from which demographic data was analysed he picked those that best fitted his hypothesis.  Had he used it all he would not have found any significant correlation.  Indeed most of the trials looking at serum cholesterol and heart disease conducted before 2000 have methodological flaws.  Confine reviews to trials after that date and even the relative risk improvement begins to look unexciting.

So there it is.  The hypothesis is based on shaky data analysis, falls over under intense scrutiny because of inherent contradictions and is also suspect because some of the later trials cannot be independently assessed.  Sceptics have persuaded erudite journals that trial data should be made available for independent analysis.  Yet one of the most strident anti-Galileans, Sir Rory Collins, refuses to do this for his own work.  If it’s so cast iron right, what is there to hide, one might ask.  And what need is there for the anti-Galileans to make snide remarks questioning the credibility and integrity of their critics? Likening us to the disgraced Andrew Wakefield, who has fooled people with fraudulent data, is frankly offensive.  We have faked no data, falsified no trials, merely picked major holes in those of others.  We have raised no scares, unlike those who have accused us of killing people by telling them to stop their statins.

What did Socrates say?  “When the debate is lost, slander becomes the tool of the loser.”

Remember: all of us sceptics were reared on the heart-cholesterol hypothesis but it is us who have been open-minded enough to question its validity.  If we are wrong, give us the evidence.  Prove that our hypothesis has fatal flaws.  In other words, put up or shut up.

 

Advertisements

HS2: the gravy train

The fron page of today’s “The Times” carries the news that large numbers of employees of the HS2 rail project are on large salaries of over £100,000 per annum.  The thing hasn’t even started building yet and the release of these figures undoubtedly plays into the hands of the naysayers who wish the whole thing would go away, and be replaced by the currently mothballed plans to upgrade the east-west routes in the north of England.  It would be cheaper and of more benefit to the economy, they say, citing “evidence” that the speed of HS2 will not result in any change in passenger numbers or convenience, It would also relieve the pressure on those whose estates are in the way of HS2 who, it must be admitted, have been treated pretty shabbily by the compensation-wallahs.

It all sounds very reasonable.  But haven’t we been here before?  The furore over HS1 is all but forgotten; all the same arguments were raised – poor homeowners forced from their land, those left bordering the line subjected to unbearable noise, shortage of passengers making the whole thing unnecessary, high fares to cover costs will be scorned by travellers.  Well.  All I can say is that it has been an unmitigated success.  I declare an interest, as I use HS1 to get to London from Ashford, but the trains are full, the speed is amazing with a halving of the old journey time, and the only complaints I ever hear are when a train is cancelled or late.

But we have been here even before that.  If we return to 1865 we find that the tunnel on the railway from London Bridge to Chislehurst at Elmstead Woods is only there because the landowner refused permission for access, and refused to allow a cutting, forcing the railway to drive a tunnel which in places is only a metre or so below the surface.  There are numerous examples of major landowners seeking special treatment during railway mania; insisting on diversions or their own stations (or both) and making just as much of a NIMBY noise as today’s complainers.  And a hundred years or so before that exactly the same happened with the canals, and in both cases people were bought off, intimidated or otherwise persuaded to give ground (pun not intended).

That isn’t to say that I lack sympathy for those in the way of HS2.  There is a clear need, though for a reassessment of the comparative costs and benefits of HS2 and HS3.  Whether, given the government’s entrenched position, this will happen is doubtful, but there must come a time when a bold decision to cancel might be wise.  Think planes, and TSR2 (look it up).

 

Why back pain treatments don’t work

A recent study suggested that many treatments for back pain do not appear to be effective.  I am unsurprised.  The first reason is that the wrong diagnosis has been made.  The second is that the treatment is, actually, ineffective.

Back pain has several causes; pain can come from a number of different structures.  It’s no good treating a disc prolapse with a muscle injection.  If the pain does not arise from a facet joint then injecting that joint will do nothing.  If the issue is a pulled back muscle then manipulation may actually make things worse.  And surgery to remove a bulging disc won’t help if the disc is not the problem.  MRI scans may help, but you can be sure if a disc bulge is on the left, and all the symptoms are on the right, then that disc bulge is irrelevant.  It is difficult, though, to persuade patients that an “abnormality” does not signify.

Thus the first key is – be sure which structure is the source of the pain.  I have an algorithm that helps, but is not infallible.  I failed to diagnose my own disc prolapse for a couple of weeks because the algorithm pointed me the wrong way.  But it’s a start.

The second key is patience.  How do you treat a bruise?  You treat the affected area with a bit of respect (not a lot) and wait for it to get better on its own.  So should you with back pain.  95% get better in four to six weeks – even disc prolapses resolve themselves quite often.  Mine did.  However there are some symptoms that should prompt the seeking of help; severe pain at night, nerve symptoms (loss of sensation or power in the leg); and especially any disturbance of bladder and bowel control.  The worrying causes of back pain are cancer or osteoporosis.  The former produces unremitting pain, the latter may have a sudden onset as a bone collapses.  The history is vital.

Treating cancer in bones is possible.  Treating pain from an osteoporotic fracture is possible, but trying to treat the osteoporosis itself will make no difference.  Time will heal the fracture and the pain will go off; anti-inflammatory drugs will help with the pain meanwhile.

I have had dramatic results from injecting anaesthetic and steroids around facet joints.  Such success may be gratifying not because it works but because it confirms the diagnosis of facet origin pain.  Spinal manipulation is positively dangerous in some circumstances.  I saw a patient who had had his neck manipulated when the cause of the pain was a large cancer deposit in one of the vertebrae which had made it vanish on X-ray; he was lucky that the manipulation did not dislocate the spine and transect the spinal cord.  I have also seen patients whose disc prolapse has been worsened by a quick tweak.  I have also seen a patient who had been diagnosed with polymyalgia (multiple central muscle pains now thought to be due to blood vessel inflammation) whose exacerbations of pain were treated with large increases in their steroid dose.  But the cause of the pain was not polymyalgia, but recurrent osteoporotic crush fractures – which the bursts of steroids were helping to create.  Folk are ever so keen to have an osteopath or chiropractor manipulate them, but there’s an awful lot of them who go back time after time for repeat treatments because they don’t last (or work).

So the first step is to make sure you have the right diagnosis, and the second is to administer the right treatment for it – or none at all.  Nothing can be a treatment.  But it’s not easy to persuade someone that nothing is better than something.  My rule was – if it’s that painful, rest it, but when it starts to improve get moving ASAP.  Bedrest can not only prolong recovery but also lead to chronic problems.  Keeping up muscle strength is vital.

There is a story of an old villager in France who had an astounding reputation for correctly identifying wines.  He could pick types, origins, even years.  Eventually during a tasting competition one of the judges slipped in a glass of water.  The old boy nosed the glass, took a sip, swilled it round and spat.  He looked puzzled.  He had a piece of bread and repeated the process, and then a third time.  Eventually he turned to the judges.  “I have never been wrong, or beaten by something” he said “but I confess that this has defeated me.  I don’t know what it is.  But I do know one thing.  It won’t sell.”

 

Sugar and spice and all things horrible

I may be boring but I have never smoked, eaten or taken cannabis in any form.  It has been around should I have wanted it but I was thoroughly put off by my father, who told terrible tales of street scenes in Bombay (now Mumbai) in his youth in the 1920s.  Men (and it was usually men) were addicted, and sat around in a zombie-like state, and he was convinced that chronic use led to serious mental illness.

Back in the 1960s, when I was a medical student, my friends pooh-poohed his lurid accounts.  “Go on! Try it!” they said.  We were in time of free love, Woodstock, California dreaming and all that.  Everybody did it.  But I never did.

Well.  Hasn’t the worm turned. The appearance of new, highly potent preparations has led to – zombie-like states, chronic addiction and the unmasking, or generation, of serious mental illness such as schizophrenia.  We have been treated to graphic scenes of drug abuse in prisons (BBC – Prison from the inside) showing not only the distressing state of users but the violence surrounding the supply of drugs.  And Spice is the big problem.  For years people have denied that cannabis and its derivatives are harmful.  I cannot believe that any denier could watch these prison scenes and persist in their denial.  Some of the users are clearly vulnerable adults and no-one is looking after them.  Perhaps no-one can.  There’s a lot of money involved so there is no incentive for suppliers to desist.

My father died forty years ago next week, but I bet he is sitting on his cloud wagging his finger and saying “I told you so”  At least it makes a change from me saying it!

 

Perpetual rediscovery

It was with wry amusement that I read a letter to “The Times” by James Harrison and published in 2003 relating to a “new discovery” about the health of Adolf Hitler, and noting that the conclusion was well-known and previously published. He termed this “perpetual rediscovery”.

During the last week – the first week of 2018 – there have been two responses to an article in the same paper which quoted England’s chief nurse as saying that missed outpatient appointments were a plague, and were costing the National Health Service perhaps as much as £1bn annually.  The subsequent correspondence pointed out that the problem of missed appointments could be resolved very simply – by overbooking.  Thus all slots would be filled, and in the rare event that everyone turned up it would just be rather a busy clinic. In any event, as the NHS did not charge if patients failed to attend, I don’t believe that any money would be lost at all; in fact, because no investigations would be generated, missed appointments might actually save money.

It was a system I used myself.  When managers questioned it, I responded that what was good enough for airlines was good enough for me.  Total rigidity was mad.  Wearing my rehab hat I used to book 45 minute slots for new patients in the multi-disciplinary clinic, because there was always a vast amount of stuff to deal with, including all the physiotherapy, occupational therapy, social work and psychology aspects of long-term severe disability.  A no-show left us all sitting doing not a lot for a long period.  Crazy – not least as for these patients the major cause of a no-show was a transport failure.

I write to “The Times” a lot.  I had four letters published in 2017, taking my total to around 70 which I reckon is a hit rate of about one in eight.  I keep a copy out of vanity.  Thus is was that I was able to recall a previous article about missed appointments, in which it had been suggested that “no-show” patients should effectively be fined (the idea was that a refundable deposit would be forfeited for a non-attendance).  In my response I said:

“…about half of missed appointments are missed because of administrative error – the appointment is sent to the wrong address, for instance… Overbooking ensures the doctor works at full efficiency.”

I annotate all my scanned letters by date, and was thus able to see that I had written this 28 years ago.

Perpetual rediscovery is, in part, a failure of institutional memory.  There is another “perpetual” in the arcane art of outpatient booking – a curious issue which I call the endless loop syndrome. Let’s suppose a patient cancels and the clinic doesn’t know. What happens next is as follows:

  • Let’s say the patient rings to cancel the day before the appointment (January 30th), and is re-booked by central appointments for 5th March
  • The patient doesn’t appear in clinic, so the clinician, not knowing of the cancellation, completes a “did not attend” (DNA) form, which generates another appointment booking through the local clinic desk. However this takes a day to process, so this re-book is for 12th March as the 5th is full
  • Patient receives the letter confirming their own rebooking for 5th March
  • Two days later they receive a second letter generated through the DNA, for 12th March. The letter says “Due to unforeseen circumstances your appointment with Dr Bamji has been changed to the 12th March”
  • The patient thinks this change refers to the appointment they made for the 5th, but this of course remains on the system
  • On 5th March the patient doesn’t appear in clinic, so the clinician completes a DNA form, which generates another appointment booking. However this takes a day to process, and is for 27th April
  • The letter confirming this is received by the patient on the 11th March, and they assume it refers to the appointment the following day, so they don’t turn up
  • On 12th March the patient doesn’t appear in clinic, so the clinician completes a DNA form, which generates another appointment booking. However this takes a day to process, and is for 9th May

And so on ad infinitum, potentially.  Actually it usually stopped after three our four iterations, because the irate patient would ring my secretary to ask what the hell was going on, and she would untangle the mess.

I monitored my DNA rate over several years.  It remained quite steady at between 10 to 15% of new appointments, and slightly less for follow-ups.  If I enquired of one of my “regulars” why they had missed, there was a reasonable excuse 90% of the time; they were ill, a relative was ill, transport had failed to collect them, snow had confined them to the house etc.  Just 10% forgot.  Text message reminders are all very well but, if generated the day before, leave no time for an empty slot to be re-filled.  And occasionally the patient had died so they were unlikely to respond – or their relatives were so devastated, and busy with arrangements, that cancelling an outpatient appointment, if indeed they knew of it, was the last thing on their mind.

So I was amused to read someone else’s solution of overbooking.  Twice.  I wonder if either of them had attended any of my trainee lectures on how to run outpatients – or indeed read my letter from 1989.  I doubt it.  Nihil novi sub sole (Ecclesiastes 1:9).

Time heals – slowly

When I retired from the NHS having worked at Queen Mary’s Hospital, Sidcup for 28 years it was with some bitterness.  During the last two years the hospital had been threatened with a merger and the likelihood of losing its A&E and maternity departments.  I was quite sure that the merger would not solve the financial problems it was supposed to, and said so in fairly forthright terms, but was ignored.  Thereafter I was threatened with disciplinary action for speaking out, and had to deal with several mischievous attempts to interfere with my clinical practice and make my working life difficult.  Despite having workload figures far in excess of any of my colleagues in the merged Trust I was told, under the counter, that I was about to be investigated for cutting sessions.  Being 60 enough was enough. In one way life was great, but I could not help feeling that my retirement was engineered.  Within six months of mt leaving my rehabilitation unit had been closed, and my sessions in the rheumatology department remained covered by locums for over three years.  So much for any legacy.

As I had predicted the new merged Trust fell to pieces – for exactly the reasons I had stated.  So schadenfreude was the order of the day,, but I failed to get the General Medical Council to deal with one medical manager whose conduct I felt had breached professional guidelines.  I also expected Queen Mary’s, now bereft of acute services, to curl up and die.

My pessimism was misplaced.  Although the hospital is managed by one Trust and has clinical services from another two, in bits, there has been what appears to be a successful and remarkable transformation.  My previous experience of acute hospitals losing their acute services was dire, with almost inevitable closure.  But somehow Queen Mary’s has reinvented itself – admittedly with the help of £30m in investment, but it now possesses a large renal dialysis unit, and spanking new and completely up to date Cancer Centre, new outpatient facilities, a splendidly redesigned front entrance, and it looks set for a long future.  More to the point the staff that I left demoralised appear to have been re-energised, and when I returned for the celebrations to re-dedicate the hospital, and also its 100 years of existence, I came home feeling that my negative attitude was now quite unnecessary; the hospital had moved on, and so would I.  It was a great pleasure to meet up with the various dinosaurs of my era and agree that everything looked pretty good.

That’s not to say that one should forget the past; there are lessons to be learned, not least in how to do things so as not to upset and irritate people, as I have described in previous essays.  It has perhaps also helped that after 25 years of trying my book “Faces from the Front” has finally come to fruition!  You can find details at http://blog.helion.co.uk/tag/faces-from-the-front/. (A great gift for anyone with an interest in plastic surgery, the First World War, facial injury etc).

So time has passed and healing has occurred.  Nonetheless I am reminded of a poem I wrote that relates to experience:

When appointed consultants, we all seemed quite young –

Looked up to our elders and betters;

But time passes by, and we cease to give tongue

Or write all those Young Turk-like letters.

And then we all find that the new ones around

Are the ones now creating the fuss –

For they carry the torch of the bright and the bold

And the elders and betters are us.

Don’t bank on it being a good idea…

The run-up to the 2017 General Election has begun, with interesting promises already being made (or in some cases, not being made) by the politicians.

Notable among the pledges is Labour’s proposal to have four new Bank Holidays.  Labour has already trumpeted its commitment to the lower-paid by suggesting an increase in the minimum wage to £10 an hour (which may mean that businesses will lay people off) but let’s look at the economics of these extra holidays…

  • Those workers paid hourly, but working an 8 hour day they will lose four days of pay, or £320.  Thus those with the owrst employment arrangements will be worse off.
  • Those businesses paying a salary will lose four days of production but still have to pay their workers the same.

Have I missed something here, or is this an oxymoronic plan?  What is the point of a holiday you end up paying for, but have to take whether you like it or not?  Of course there is, on top of this, the disruption that will occur in the NHS, which Labour pledges to protect.  Bank Holidays are already a nightmare.  All non-emergency services shut down; no cold surgery, no outpatients.  There will be a rapid increase in waits.  Think about it.  Senior doctors have six weeks leave and two weeks of study leave, which means that at most they work a 44 week year.  Those who have commitments on Mondays lose six this year to Bank Holidays (in England) so are now down to 36 weeks.  Another two weekdays go for Christmas.  Then we are to lose another four days – which is nearly another whole week (OK, they won’t all be Mondays but a week is a week).

Would you trust the originators of this madcap scheme with your money?  Leave aside that they will take even more of it to fund all their other crackpot plans.

I have a rule for plans.  Look at an idea, and work out whether there is anything that could possibly go wrong with it.  Look at every angle; assess the pros, but search for the cons.  In this case it is one big con, in every sense of the word.